NeoGenomics plays an essential role in helping our Pharma partners through therapeutic development and approval, saving thousands of lives around the world in the process.
Fort Myers, FL 33912
Aliso Viejo, CA 92656
Atlanta, GA 30345
Babraham Research Park
Cambridge CB22 3FH,
Carlsbad, CA 92008
Tinley Park, IL 60477
Durham, NC 27709
Houston, TX 77085
San Diego, CA 92121
Temple Terrace, FL 33637
Our customers include 19 of the top 20 oncology biopharma companies
Transfer and validate biomarker assays: Our dedicated team of experts will work with you to understand your challenges and suggest potential solutions, including clinical trial support and post clinical trial services.
The technologies offered at NeoGenomics had advantages over other CRO's we explored including the ability to obtain high quality RNAseq data from challenging starting materials such as FFPE and the ability of MultiOmyx® technology to measure multiple markers within a single FFPE slide while avoiding the issue of spectral overlap that arise from more traditional immunofluorescence approaches.
The NeoGenomics team has the technical expertise to develop and qualify novel multiplexing assays to support preclinical and clinical testing of samples from clinical studies to the highest standards. The technical team has been very collaborative and interactive with the IAVI team and paid close attention to the client's requirements.
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients